(Q38115193)

29 August 2017

Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma (English)

1 reference

Theodorus H Van der Kwast

29 August 2017

Najla Aldaoud

3

0 references

object named as

Theodorus H van der Kwast

6

0 references

author name string

Michelle R Downes

1

1 reference

29 August 2017

Emina E Torlakovic

2

1 reference

29 August 2017

Alexandre R Zlotta

4

1 reference

29 August 2017

Andrew J Evans

5

1 reference

29 August 2017

language of work or name

English

0 references

publication date

17 June 2013

1 reference

Journal of Clinical Pathology

29 August 2017

1 reference

29 August 2017

66

1 reference

29 August 2017

9

1 reference

29 August 2017

779-786

1 reference

The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate.

29 August 2017

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

The endocrinology and developmental biology of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Androgen receptor expression in human tissues: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Prostate androgen receptor: immunohistological localization and mRNA characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Bladder cancer: epidemiology, staging and grading, and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

The androgen receptor revisited in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Morphological changes induced by androgen blockade in normal prostate and prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Treatment effects in the prostate including those associated with traditional and emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201586

10.1136/JCLINPATH-2013-201586

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference